Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
14:38 | Centurion One Capital Corp.: Mobile-health Network Solutions to Present at Centurion One Capital 8th Annual Growth Conference | 145 | Newsfile | Singapore, Singapore--(Newsfile Corp. - February 27, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a pioneering MedTech company dedicated to enhancing human connection... ► Artikel lesen | |
19.02. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
MOBILE-HEALTH NETWORK SOLUTIONS Aktie jetzt für 0€ handeln | |||||
04.02. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
17.01. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
26.12.24 | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
17.12.24 | Mobile-health Network Solutions Launches ManaSocial, New Digital Healthcare Engagement Platform Expected to Accelerate Growth | 3 | GlobeNewswire (USA) | ||
23.10.24 | Mobile-health Network Solutions Reports 77 Percent Revenue Increase for Fiscal Year 2024 | 218 | GlobeNewswire (Europe) | SINGAPORE, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that for the fiscal... ► Artikel lesen | |
23.10.24 | Mobile-health Network Solutions - 20-F, Annual and transition report of foreign private issuers | 2 | SEC Filings | ||
15.10.24 | Mobile-health Network Solutions Announces Participation in the LD Micro Main Event XVII | 233 | Newsfile | Singapore, Singapore--(Newsfile Corp. - October 15, 2024) - Mobile-health Network Solutions (NASDAQ: MNDR), a leading Asia-Pacific telehealth provider, announced today that it will be presenting at... ► Artikel lesen | |
30.09.24 | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
27.09.24 | Mobile-health Network Solutions to Present at Two Financial Conferences for October 2024 | 3 | GlobeNewswire (USA) | ||
23.09.24 | Mobile-health Network Solutions receives Nasdaq notice of non-compliance | 2 | Seeking Alpha | ||
21.09.24 | Mobile-health Network Solutions Delinquency Notification Letter From Nasdaq | 302 | GlobeNewswire (Europe) | SINGAPORE, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that it received... ► Artikel lesen | |
20.09.24 | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
06.09.24 | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
19.06.24 | Mobile-health Network Solutions Pte Ltd: Mobile-health Network Solutions [MaNaDr] to Offer GLP-1 Injectables for Medical Weight Loss from USD10/Day | 514 | JCN Newswire | SINGAPORE, June 19, 2024 - (NewMediaWire) - Mobile-health Network Solutions ['MaNaDr'](Nasdaq: MNDR), a leading Asia-Pacific telehealth provider, today announced updated pricing for its medical weight... ► Artikel lesen | |
21.05.24 | Mobile-health Network Solutions Revenue Rises Approximately 120% in the First Six Months of Fiscal 2024 | 263 | GlobeNewswire (Europe) | SINGAPORE, May 21, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that for the first... ► Artikel lesen | |
22.04.24 | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | 276 | GlobeNewswire (Europe) | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
15.04.24 | Mobile-health Network Solutions Makes History as First APAC Telehealth Company Listed on US Stock Exchange | 439 | GlobeNewswire (Europe) | SINGAPORE, April 15, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR), a pioneering Asia-Pacific (APAC) telehealth provider, celebrates its successful initial public offering... ► Artikel lesen | |
13.04.24 | Mobile-health Network Solutions Announces Closing of Initial Public Offering | 857 | GlobeNewswire (Europe) | SINGAPORE, April 12, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions ("MNDR" or "the Company"), a leading telehealth solutions provider in Singapore, today announced the closing of its previously... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA BIOTHERAPEUTICS | 0,130 | -0,46 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 13.02.2025 | Das Instrument PSH0 CA81752F1062 SERNOVA BIOTHERAPEUTICS EQUITY hat seinen ersten Handelstag am 13.02.2025: CONTINUOUS TRADING WITH AUCTIONS, PAG NAM0, SettlCurr EUR, CCP Y
The instrument PSH0 CA81752F1062... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,727 | +2,11 % | ATOSSA THERAPEUTICS, INC. - 8-K, Current Report | ||
PING AN HEALTHCARE | 1,035 | -3,50 % | Ping An Healthcare and Technology Company Limited: Ping An Health Pioneers AI-Driven Healthcare with DeepSeek Integration | HONG KONG and SHANGHAI, Feb. 13, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: 1833.HK) recently... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,014 | -23,66 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
CO-DIAGNOSTICS | 0,510 | +3,24 % | Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance | The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component
SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/... ► Artikel lesen | |
CYTOSORBENTS | 1,060 | +1,92 % | CytoSorbents sichert sich 1,6 Millionen US-Dollar durch Optionsscheinausübungen | ||
VERU | 0,494 | -2,47 % | Veru Inc. Direktor Michael Rankowitz erwirbt Stammaktien im Wert von 84.350 US-Dollar | ||
TEMPEST THERAPEUTICS | 0,790 | +0,51 % | Tempest Therapeutics: Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma | Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC Amezalpat builds momentum with both Fast Track and Orphan Drug Designations BRISBANE, Calif.... ► Artikel lesen | |
VOLITIONRX | 0,575 | 0,00 % | VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for
Friday, November 15 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., Nov. 14, 2024... ► Artikel lesen | |
EKSO BIONICS | 0,532 | +5,56 % | Ekso Bionics Holdings Aktie: Droht der Durchbruch zu scheitern? | Die Ekso Bionics Holdings verzeichnete am 22. Februar 2025 einen Kursrückgang von 1,44 Prozent auf 0,5525 USD. Der Hersteller von medizinischen Exoskeletten steht kurz vor der Veröffentlichung seiner... ► Artikel lesen | |
IMUNON | 0,850 | +8,97 % | Imunon, Inc.: IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study | IMNN-001 remains the first immunotherapy to achieve a meaningful overall survival benefit in advanced ovarian cancer Patient enrollment in Phase 3 pivotal trial of IMNN-001 scheduled to begin in... ► Artikel lesen | |
BEYOND AIR | 0,298 | +2,05 % | Beyond Air COO Michael Gaul erwirbt Stammaktien im Wert von 2.293 US-Dollar | ||
AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
NOVACYT | 0,605 | +1,34 % | Novacyt S.A. - IVDR accreditation for Yourgene QST*R Base assay | ||
AROVELLA THERAPEUTICS | 0,086 | +11,69 % | XFRA E4NA: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |